Interleukin-19: Multiple roles in immune regulation and disease

Cytokine and Growth Factor Reviews

Volumn 21, Issue 5, 2010, Pages 345-352

  Gallagher, Grant ^a  

^a HUMIGEN LLC   (United States)

Author keywords

Asthma; IL 19; Psoriasis; Th2

Indexed keywords

CYTOKINE RECEPTOR; INTERLEUKIN 19; INTERLEUKIN 19 RECEPTOR; INTERLEUKIN 20; INTERLEUKIN 24; MESSENGER RNA; UNCLASSIFIED DRUG;

ASTHMA; COMPLEX FORMATION; CYTOKINE PRODUCTION; FEEDBACK SYSTEM; GENE EXPRESSION; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATORY DISEASE; KERATINOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PSORIASIS; REVIEW; SEPTIC SHOCK; SIGNAL TRANSDUCTION; TH2 CELL; TRANSCRIPTION REGULATION;

ANIMALS; ASTHMA; HUMANS; INTERLEUKINS; PSORIASIS; TH2 CELLS;

ANIMALIA;

EID: 78649734555     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2010.08.005     Document Type: Review

References (101)

1. Gallagher G., Eskdale J., Sabat R., Wolk K. Interleukin-19. Class II Cytokines 2007, 127-144. Transworld Research Network, Kerala, India. A. Zdanov (Ed.).
2. Bartlett N.W., Dumoutier L., Renauld J.C., Kotenko S.V., McVey C.E., Lee H.J., et al. A new member of the interleukin 10-related cytokine family encoded by a poxvirus. J Gen Virol 2004, 85:1401-1412.
3. Savan R., Ravichandran S., Collins J.R., Sakai M., Young H.A. Structural conservation of interferon gamma among vertebrates. Cytokine Growth Factor Rev 2009, 20:115-124.
4. Wolk K., Kunz S., Asadullah K., Sabat R. Cutting edge: immune cells as sources and targets of the IL-10 family members?. J Immunol 2002, 168:5397-5402.
5. Menon R., Ismail L., Ismail D., Merialdi M., Lombardi S.J., Fortunato S.J. Human fetal membrane expression of IL-19 and IL-20 and its differential effect on inflammatory cytokine production. J Matern Fetal Neonatal Med 2006, 19:209-214.
6. Okayama N., Suehiro Y., Hamanaka Y., Nakamura J., Hinoda Y. Association of interleukin-19 gene polymorphisms with age. J Gerontol A: Biol Sci Med Sci 2007, 62:507-511.
7. Barrett J.C., Clayton D.G., Concannon P., Akolkar B., Cooper J.D., Erlich H.A., et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009, 41:703-707.
8. Hsing C.H., Chiu C.J., Chang L.Y., Hsu C.C., Chang M.S. IL-19 is involved in the pathogenesis of endotoxic shock. Shock 2008, 29:7-15.
9. Pinkerton M.N., Wescott D.C., Gaffey B.J., Beggs K.T., Milne T.J., Meikle M.C. Cultured human periodontal ligament cells constitutively express multiple osteotropic cytokines and growth factors, several of which are responsive to mechanical deformation. J Periodontal Res 2008, 43:343-351.
10. Cuneo A.A., Herrick D., Autieri M.V. IL-19 reduces VSMC activation by regulation of mRNA regulatory factor HuR and reduction of mRNA stability. J Mol Cell Cardiol 2010, 49(4):647-654.
11. Sakurai N., Kuroiwa T., Ikeuchi H., Hiramatsu N., Maeshima A., Kaneko Y., et al. Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation. Rheumatology (Oxford) 2008, 47:815-820.
12. Alanara T., Karstila K., Moilanen T., Silvennoinen O., Isomaki P. Expression of IL-10 family cytokines in rheumatoid arthritis: elevated levels of IL-19 in the joints. Scand J Rheumatol 2010, 39:118-126.
13. Gallagher G., Dickensheets H., Eskdale J., Izotova L.S., Mirochnitchenko O.V., Peat J.D., et al. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun 2000, 1:442-450.
14. Jones E.A., Flavell R.A. Distal enhancer elements transcribe intergenic RNA in the IL-10 family gene cluster. J Immunol 2005, 175:7437-7446.
15. Kan S.H., Mancini G., Gallagher G. Identification and characterization of multiple splice forms of the human interleukin-23 receptor alpha chain in mitogen-activated leukocytes. Genes Immun 2008, 9:631-639.
16. Mancini G., Kan S.H., Gallagher G. A novel insertion variant of the human IL-23 receptor-alpha chain transcript. Genes Immun 2008, 9:566-569.
17. Ronninger M., Eklow C., Lorentzen J.C., Klareskog L., Padyukov L. Differential expression of transcripts for the autoimmunity-related human dendritic cell immunoreceptor. Genes Immun 2008, 9:412-418.
18. Vincent B.H., Montufar-Solis D., Teng B.B., Amendt B.A., Schaefer J., Klein J.R. Bone marrow cells produce a novel TSHbeta splice variant that is upregulated in the thyroid following systemic virus infection. Genes Immun 2009, 10:18-26.
19. Vudattu N.K., Magalhaes I., Hoehn H., Pan D., Maeurer M.J. Expression analysis and functional activity of interleukin-7 splice variants. Genes Immun 2009, 10:132-140.
20. Wei C.C., Chang M.S. A novel transcript of mouse interleukin-20 receptor acts on glomerular mesangial cells as an aggravating factor in lupus nephritis. Genes Immun 2008, 9:668-679.
21. Wei C.C., Chang M.S. Mouse interleukin-20 receptor 1a targets renal epithelial cells and is associated with renal calcium deposition. Genes Immun 2009, 10:237-247.
22. Nishimura H., Yajima T., Naiki Y., Tsunobuchi H., Umemura M., Itano K., et al. Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo. J Exp Med 2000, 191:157-170.
23. Waldmann T.A., Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol 1999, 17:19-49.
24. Eskdale J., Kube D., Tesch H., Gallagher G. Mapping of the human IL10 gene and further characterization of the 5' flanking sequence. Immunogenetics 1997, 46:120-128.
25. Eskdale J., Gallagher G., Verweij C.L., Keijsers V., Westendorp R.G., Huizinga T.W. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 1998, 95:9465-9470.
26. Eskdale J., Keijsers V., Huizinga T., Gallagher G. Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun 1999, 1:151-155.
27. Kube D., Rieth H., Eskdale J., Kremsner P.G., Gallagher G. Structural characterisation of the distal 5' flanking region of the human interleukin-10 gene. Genes Immun 2001, 2:181-190.
28. Mormann M., Rieth H., Hua T.D., Assohou C., Roupelieva M., Hu S.L., et al. Mosaics of gene variations in the interleukin-10 gene promoter affect interleukin-10 production depending on the stimulation used. Genes Immun 2004, 5:246-255.
29. Rieth H., Mormann M., Luty A.J., Assohou-Luty C.A., Roupelieva M., Kremsner P.G., et al. A three base pair gene variation within the distal 5'-flanking region of the interleukin-10 (IL-10) gene is related to the in vitro IL-10 production capacity of lipopolysaccharide-stimulated peripheral blood mononuclear cells. Eur Cytokine Netw 2004, 15:153-158.
30. Grundtner P., Gruber S., Murray S.S., Vermeire S., Rutgeerts P., Decker T., et al. The IL-10R1 S138G loss-of-function allele and ulcerative colitis. Genes Immun 2009, 10:84-92.
31. Larsson L., Johansson P., Jansson A., Donati M., Rymo L., Berglundh T. The Sp1 transcription factor binds to the G-allele of the -1087 IL-10 gene polymorphism and enhances transcriptional activation. Genes Immun 2009, 10:280-284.
32. Pereira A.C., Brito-de-Souza V.N., Cardoso C.C., Dias-Baptista I.M., Parelli F.P., Venturini J., et al. Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for -819C/T in leprosy susceptibility. Genes Immun 2009, 10:174-180.
33. Liao Y.C., Liang W.G., Chen F.W., Hsu J.H., Yang J.J., Chang M.S. IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha. J Immunol 2002, 169:4288-4297.
34. Finch P.W., Murphy F., Cardinale I., Krueger J.G. Altered expression of keratinocyte growth factor and its receptor in psoriasis. Am J Pathol 1997, 151:1619-1628.
35. Li H.H., Lin Y.C., Chen P.J., Hsiao C.H., Lee J.Y., Chen W.C., et al. Interleukin-19 upregulates keratinocyte growth factor and is associated with psoriasis. Br J Dermatol 2005, 153:591-595.
36. Koks S., Kingo K., Ratsep R., Karelson M., Silm H., Vasar E. Combined haplotype analysis of the interleukin-19 and -20 genes: relationship to plaque-type psoriasis. Genes Immun 2004, 5:662-667.
37. Koks S., Kingo K., Vabrit K., Ratsep R., Karelson M., Silm H., et al. Possible relations between the polymorphisms of the cytokines IL-19, IL-20 and IL-24 and plaque-type psoriasis. Genes Immun 2005, 6:407-415.
38. Chen P.J., Wei C.C., Wang C., Chen F.W., Hsu Y.H., Chang M.S. Promoter analysis of interleukin 19. Biochem Biophys Res Commun 2006, 344:713-720.
39. Huang F., Wachi S., Thai P., Loukoianov A., Tan K.H., Forteza R.M., et al. Potentiation of IL-19 expression in airway epithelia by IL-17A and IL-4/IL-13: important implications in asthma. J Allergy Clin Immunol 2008, 121. 1415-21, 1421.e1-3.
40. Chang C., Magracheva E., Kozlov S., Fong S., Tobin G., Kotenko S., et al. Crystal structure of interleukin-19 defines a new subfamily of helical cytokines. J Biol Chem 2003, 278:3308-3313.
41. Jordan W.J., Eskdale J., Boniotto M., Lennon G.P., Peat J., Campbell J.D., et al. Human IL-19 regulates immunity through auto-induction of IL-19 and production of IL-10. Eur J Immunol 2005, 35:1576-1582.
42. Gallagher G., Eskdale J., Jordan W.J., Boniotto M., Rodia M., Kelner D., et al. Human interleukin-19: structure, function and disease associations. Anti-Inflamm Anti-Allergy Agents Med Sci 2006, 5:233-242.
43. Sa S.M., Valdez P.A., Wu J., Jung K., Zhong F., Hall L., et al. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J Immunol 2007, 178:2229-2240.
44. Dumoutier L., Leemans C., Lejeune D., Kotenko S.V., Renauld J.C. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol 2001, 167:3545-3549.
45. Blumberg H., Conklin D., Xu W.F., Grossmann A., Brender T., Carollo S., et al. Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 2001, 104:9-19.
46. Parrish-Novak J., Xu W., Brender T., Yao L., Jones C., West J., et al. Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J Biol Chem 2002, 277:47517-47523.
47. Pletnev S., Magracheva E., Kozlov S., Tobin G., Kotenko S.V., Wlodawer A., et al. Characterization of the recombinant extracellular domains of human interleukin-20 receptors and their complexes with interleukin-19 and interleukin-20. Biochemistry 2003, 42:12617-12624.
48. Wang M., Tan Z., Zhang R., Kotenko S.V., Liang P. Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2. J Biol Chem 2002, 277:7341-7347.
49. Wahl C., Muller W., Leithauser F., Adler G., Oswald F., Reimann J., et al. IL-20 receptor 2 signaling down-regulates antigen-specific T cell responses. J Immunol 2009, 182:802-810.
50. Kunz S., Wolk K., Witte E., Witte K., Doecke W.D., Volk H.D., et al. Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs. Exp Dermatol 2006, 15:991-1004.
51. Wolk K., Witte K., Witte E., Proesch S., Schulze-Tanzil G., Nasilowska K., et al. Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes. J Leukoc Biol 2008, 83:1181-1193.
52. Nagalakshmi M.L., Murphy E., McClanahan T., de Waal Malefyt R. Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization. Int Immunopharmacol 2004, 4:577-592.
53. Tian Y., Sommerville L.J., Cuneo A., Kelemen S.E., Autieri M.V. Expression and suppressive effects of interleukin-19 on vascular smooth muscle cell pathophysiology and development of intimal hyperplasia. Am J Pathol 2008, 173:901-909.
54. Piessevaux J., Lavens D., Peelman F., Tavernier J. The many faces of the SOCS box. Cytokine Growth Factor Rev 2008, 19:371-381.
55. Azuma Y.T., Matsuo Y., Kuwamura M., Yancopoulos G.D., Valenzuela D.M., Murphy A.J., et al. Interleukin-19 protects mice from innate-mediated colonic inflammation. Inflamm Bowel Dis 2009.
56. Stern R.S., Nijsten T., Feldman S.R., Margolis D.J., Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Invest Dermatol Symp Proc 2004, 9:136-139.
57. Gelfand J.M., Feldman S.R., Stern R.S., Thomas J., Rolstad T., Margolis D.J. Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol 2004, 51:704-708.
58. Sander H.M., Morris L.F., Phillips C.M., Harrison P.E., Menter A. The annual cost of psoriasis. J Am Acad Dermatol 1993, 28:422-425.
59. Tse W.P., Che C.T., Liu K., Lin Z.X. Evaluation of the anti-proliferative properties of selected psoriasis-treating Chinese medicines on cultured HaCaT cells. J Ethnopharmacol 2006, 108:133-141.
60. Gottlieb S.L., Gilleaudeau P., Johnson R., Estes L., Woodworth T.G., Gottlieb A.B., et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med 1995, 1:442-447.
61. Prinz J.C. The role of T cells in psoriasis. J Eur Acad Dermatol Venereol 2003, 17:257-270.
62. Ghoreschi K., Weigert C., Rocken M. Immunopathogenesis and role of T cells in psoriasis. Clin Dermatol 2007, 25:574-580.
63. Asadullah K., Docke W.D., Volk H.D., Sterry W. The pathophysiological role of cytokines in psoriasis. Drugs Today (Barc) 1999, 35:913-924.
64. Wei C.C., Chen W.Y., Wang Y.C., Chen P.J., Lee J.Y., Wong T.W., et al. Detection of IL-20 and its receptors on psoriatic skin. Clin Immunol 2005, 117:65-72.
65. Ghoreschi K., Thomas P., Breit S., Dugas M., Mailhammer R., van Eden W., et al. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat Med 2003, 9:40-46.
66. Romer J., Hasselager E., Norby P.L., Steiniche T., Thorn Clausen J., Kragballe K. Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol. J Invest Dermatol 2003, 121:1306-1311.
67. Otkjaer K., Kragballe K., Funding A.T., Clausen J.T., Noerby P.L., Steiniche T., et al. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis. Br J Dermatol 2005, 153:911-918.
68. Wang F., Lee E., Lowes M.A., Haider A.S., Fuentes-Duculan J., Abello M.V., et al. Prominent production of IL-20 by CD68+/CD11c+ myeloid-derived cells in psoriasis: gene regulation and cellular effects. J Invest Dermatol 2006, 126:1590-1599.
69. Gallagher G., Eskdale J., Jordan W., Peat J., Campbell J., Boniotto M., et al. Human interleukin-19 and its receptor: a potential role in the induction of Th2 responses. Int Immunopharmacol 2004, 4:615-626.
70. Asadullah K., Eskdale J., Wiese A., Gallagher G., Friedrich M., Sterry W. Interleukin-10 promoter polymorphism in psoriasis. J Invest Dermatol 2001, 116:975-978.
71. Smith A.J., Humphries S.E. Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 2009, 20:43-59.
72. Heron M., Grutters J.C., van Moorsel C.H., Ruven H.J., Huizinga T.W., van der Helm-van Mil A.H., et al. Variation in IL7R predisposes to sarcoid inflammation. Genes Immun 2009, 10:647-653.
73. Wieczorek S., Hoffjan S., Chan A., Rey L., Harper L., Fricke H., et al. Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener's granulomatosis and confirmation for multiple sclerosis in German patients. Genes Immun 2009, 10:591-595.
74. Morris D.L., Graham R.R., Erwig L.P., Gaffney P.M., Moser K.L., Behrens T.W., et al. Variation in the upstream region of P-Selectin (SELP) is a risk factor for SLE. Genes Immun 2009, 10:404-413.
75. Alcina A., Vandenbroeck K., Otaegui D., Saiz A., Gonzalez J.R., Fernandez O., et al. The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis. Genes Immun 2010, 11(5):439-445.
76. Jamieson S.E., Peixoto-Rangel A.L., Hargrave A.C., Roubaix L.A., Mui E.J., Boulter N.R., et al. Evidence for associations between the purinergic receptor P2X(7) (P2RX7) and toxoplasmosis. Genes Immun 2010, 11:374-383.
77. Kingo K., Mossner R., Koks S., Ratsep R., Kruger U., Vasar E., et al. Association analysis of IL19, IL20 and IL24 genes in palmoplantar pustulosis. Br J Dermatol 2007, 156:646-652.
78. Kingo K., Mossner R., Ratsep R., Raud K., Kruger U., Silm H., et al. Association analysis of IL20RA and IL20RB genes in psoriasis. Genes Immun 2008, 9:445-451.
79. Kingo K., Mossner R., Traks T., Ratsep R., Raud K., Reimann E., et al. Further association analysis of chr 6q22-24 suggests a role of IL-20RA polymorphisms in psoriasis. J Dermatol Sci 2010, 57:71-73.
80. Wolk K., Haugen H.S., Xu W., Witte E., Waggie K., Anderson M., et al. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J Mol Med 2009, 87:523-536.
81. Wolk K., Witte E., Warszawska K., Schulze-Tanzil G., Witte K., Philipp S., et al. The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis. Eur J Immunol 2009, 39:3570-3581.
82. Oral H.B., Kotenko S.V., Yilmaz M., Mani O., Zumkehr J., Blaser K., et al. Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26. Eur J Immunol 2006, 36:380-388.
83. Hummelshoj L., Ryder L.P., Poulsen L.K. The role of the interleukin-10 subfamily members in immunoglobulin production by human B cells. Scand J Immunol 2006, 64:40-47.
84. Liao S.C., Cheng Y.C., Wang Y.C., Wang C.W., Yang S.M., Yu C.K., et al. IL-19 induced Th2 cytokines and was up-regulated in asthma patients. J Immunol 2004, 173:6712-6718.
85. Kim S., Miska K.B., McElroy A.P., Jenkins M.C., Fetterer R.H., Cox C.M., et al. Molecular cloning and functional characterization of avian interleukin-19. Mol Immunol 2009, 47:476-484.
86. Hsing C.H., Hsu C.C., Chen W.Y., Chang L.Y., Hwang J.C., Chang M.S. Expression of IL-19 correlates with Th2 cytokines in uraemic patients. Nephrol Dial Transplant 2007, 22:2230-2238.
87. Li Z., Liu B., Maminishkis A., Mahesh S.P., Yeh S., Lew J., et al. Gene expression profiling in autoimmune noninfectious uveitis disease. J Immunol 2008, 181:5147-5157.
88. Crain E.F., Weiss K.B., Fagan M.J. Pediatric asthma care in US emergency departments. Current practice in the context of the National Institutes of Health guidelines. Arch Pediatr Adolesc Med 1995, 149:893-901.
89. Walker C., Kaegi M.K., Braun P., Blaser K., Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991, 88:935-942.
90. Walker C., Bode E., Boer L., Hansel T.T., Blaser K., Virchow J.C.J., et al. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992, 146:109-115.
91. Robinson D.S., Hamid Q., Ying S., Tsicopoulos A., Barkans J., Bentley A.M., et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992, 326:298-304.
92. Mattes J., Yang M., Siqueira A., Clark K., MacKenzie J., McKenzie A.N., et al. IL-13 induces airways hyperreactivity independently of the IL-4R alpha chain in the allergic lung. J Immunol 2001, 167:1683-1692.
93. Zhao Y., Yang J., Gao Y.D., Guo W. Th17 immunity in patients with allergic asthma. Int Arch Allergy Immunol 2009, 151:297-307.
94. Zhong H., Wu Y., Belardinelli L., Zeng D. A2B adenosine receptors induce IL-19 from bronchial epithelial cells, resulting in TNF-alpha increase. Am J Respir Cell Mol Biol 2006, 35:587-592.
95. Curtin N.M., Mills K.H., Connor T.J. Psychological stress increases expression of IL-10 and its homolog IL-19 via beta-adrenoceptor activation: reversal by the anxiolytic chlordiazepoxide. Brain Behav Immun 2009, 23:371-379.
96. Walter D.M., McIntire J.J., Berry G., McKenzie A.N., Donaldson D.D., DeKruyff R.H., et al. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J Immunol 2001, 167:4668-4675.
97. Finotto S., Hausding M., Doganci A., Maxeiner J.H., Lehr H.A., Luft C., et al. Asthmatic changes in mice lacking T-bet are mediated by IL-13. Int Immunol 2005, 17:993-1007.
98. Kaur D., Hollins F., Woodman L., Yang W., Monk P., May R., et al. Mast cells express IL-13R alpha 1: IL-13 promotes human lung mast cell proliferation and Fc epsilon RI expression. Allergy 2006, 61:1047-1053.
99. Kotenko S.V., Gallagher G., Baurin V.V., Lewis-Antes A., Shen M., Shah N.K., et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003, 4:69-77.
100. Dellgren C., Gad H.H., Hamming O.J., Melchjorsen J., Hartmann R. Human interferon-lambda3 is a potent member of the type III interferon family. Genes Immun 2009, 10:125-131.
101. Kotenko S.V., Saccani S., Izotova L.S., Mirochnitchenko O.V., Pestka S. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci USA 2000, 97:1695-1700.